| Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
|---|
| C029790 |
2,2',3',4,4',5-hexachlorobiphenyl |
[2,4,4'-trichlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,3',4,4',5-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of KDR mRNA | affects cotreatment|increases expression | 15808785
|
| C070055 |
2,3',4,4',5-pentachlorobiphenyl |
[2,4,4'-trichlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,3',4,4',5-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of KDR mRNA | affects cotreatment|increases expression | 15808785
|
| C029498 |
2,3-bis(3'-hydroxybenzyl)butane-1,4-diol |
2,3-bis(3'-hydroxybenzyl)butane-1,4-diol inhibits the reaction [Estradiol results in increased expression of KDR protein] | decreases reaction|increases expression | 17289903
|
| C029497 |
2,3-bis(3'-hydroxybenzyl)butyrolactone |
2,3-bis(3'-hydroxybenzyl)butyrolactone inhibits the reaction [Estradiol results in increased expression of KDR protein] | decreases reaction|increases expression | 17289903
|
| C081766 |
2,4,4'-trichlorobiphenyl |
[2,4,4'-trichlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,3',4,4',5-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of KDR mRNA | affects cotreatment|increases expression | 15808785
|
| C014024 |
2,4,5,2',4',5'-hexachlorobiphenyl |
[2,4,4'-trichlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,3',4,4',5-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of KDR mRNA | affects cotreatment|increases expression | 15808785
|
| C009828 |
2,4,5,2',5'-pentachlorobiphenyl |
[2,4,4'-trichlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,3',4,4',5-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of KDR mRNA | affects cotreatment|increases expression | 15808785
|
| C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of KDR mRNA | affects expression | 21346803
|
| C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of KDR mRNA | affects expression | 21346803
|
| C500344 |
2-methoxyestradiol-3,17-bis-O,O-sulfamate |
2-methoxyestradiol-3,17-bis-O,O-sulfamate analog results in decreased expression of KDR protein | decreases expression | 17426705
|
| C500344 |
2-methoxyestradiol-3,17-bis-O,O-sulfamate |
2-methoxyestradiol-3,17-bis-O,O-sulfamate results in decreased expression of KDR protein | decreases expression | 17426705
|
| C022960 |
2-oxindole |
2-oxindole analog results in decreased activity of KDR protein | decreases activity | 15728459
|
| C028451 |
3,4,3',4'-tetrachlorobiphenyl |
[3,4,3',4'-tetrachlorobiphenyl co-treated with 3,4,5,3',4'-pentachlorobiphenyl co-treated with 3,4,5,3',4',5'-hexachlorobiphenyl] results in increased expression of KDR mRNA | affects cotreatment|increases expression | 15808785
|
| C027309 |
3,4,5,3',4',5'-hexachlorobiphenyl |
[3,4,3',4'-tetrachlorobiphenyl co-treated with 3,4,5,3',4'-pentachlorobiphenyl co-treated with 3,4,5,3',4',5'-hexachlorobiphenyl] results in increased expression of KDR mRNA | affects cotreatment|increases expression | 15808785
|
| C023035 |
3,4,5,3',4'-pentachlorobiphenyl |
[3,4,3',4'-tetrachlorobiphenyl co-treated with 3,4,5,3',4'-pentachlorobiphenyl co-treated with 3,4,5,3',4',5'-hexachlorobiphenyl] results in increased expression of KDR mRNA | affects cotreatment|increases expression | 15808785
|
| C500067 |
3-((5-(6-((3-chlorophenyl)amino)pyrazinyl)-3-pyridinyl)amino)-1-propanol |
3-((5-(6-((3-chlorophenyl)amino)pyrazinyl)-3-pyridinyl)amino)-1-propanol binds to and results in decreased activity of KDR protein | affects binding|decreases activity | 15771433
|
| C477639 |
3-(5-methyl-2-(2-oxo-1,2-dihydroindol-3-ylidenemethyl)-1H-pyrrol-3-yl)propionic acid |
3-(5-methyl-2-(2-oxo-1,2-dihydroindol-3-ylidenemethyl)-1H-pyrrol-3-yl)propionic acid results in decreased activity of KDR protein | decreases activity | 12766257
|
| C010643 |
6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid |
6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid results in decreased expression of KDR protein | decreases expression | 17992120
|
| D000082 |
Acetaminophen |
Acetaminophen results in increased expression of KDR mRNA | increases expression | 17431590
|
| D000082 |
Acetaminophen |
Acetaminophen results in increased expression of KDR protein | increases expression | 17431590
|
| D000111 |
Acetylcysteine |
Acetylcysteine results in increased expression of KDR protein | increases expression | 17992120
|
| D000638 |
Amiodarone |
Amiodarone affects the expression of KDR mRNA | affects expression | 19483382
|
| D001374 |
Azacitidine |
Azacitidine results in increased expression of KDR mRNA | increases expression | 18037191
|
| D001553 |
Benzbromarone |
Benzbromarone affects the expression of KDR mRNA | affects expression | 19483382
|
| D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of KDR mRNA | decreases expression | 20106945
|
| C070515 |
bisindolylmaleimide I |
bisindolylmaleimide I inhibits the reaction [AGT protein results in increased expression of KDR mRNA] | decreases reaction|increases expression | 15005273
|
| D002994 |
Clofibrate |
Clofibrate affects the expression of KDR mRNA | affects expression | 19483382
|
| D002995 |
Clofibric Acid |
[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of KDR mRNA | affects cotreatment|affects expression | 17602206
|
| D003008 |
Cloprostenol |
Cloprostenol results in decreased expression of KDR mRNA | decreases expression | 14991729
|
| D003300 |
Copper |
Copper results in decreased expression of KDR protein | decreases expression | 19542178
|
| D003474 |
Curcumin |
Curcumin affects the expression of KDR mRNA | affects expression | 17960570
|
| D003474 |
Curcumin |
Curcumin inhibits the reaction [Dietary Fats results in increased expression of KDR mRNA] | decreases reaction|increases expression | 19297423
|
| D003520 |
Cyclophosphamide |
Cyclophosphamide results in decreased expression of KDR mRNA | decreases expression | 19701751
|
| D003520 |
Cyclophosphamide |
Cyclophosphamide results in decreased expression of KDR protein | decreases expression | 19701751
|
| D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of KDR mRNA | decreases expression | 20106945
|
| C107676 |
deguelin |
deguelin metabolite results in decreased expression of KDR protein | decreases expression | 19139008
|
| C107676 |
deguelin |
deguelin results in decreased expression of KDR protein | decreases expression | 19139008
|
| C050229 |
demethoxycurcumin |
demethoxycurcumin affects the expression of KDR mRNA | affects expression | 17960570
|
| D004041 |
Dietary Fats |
Curcumin inhibits the reaction [Dietary Fats results in increased expression of KDR mRNA] | decreases reaction|increases expression | 19297423
|
| D004041 |
Dietary Fats |
Dietary Fats results in increased expression of KDR mRNA | increases expression | 19297423 18042831
|
| D004052 |
Diethylnitrosamine |
[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of KDR mRNA | affects cotreatment|affects expression | 17602206
|
| D004052 |
Diethylnitrosamine |
Diethylnitrosamine results in decreased expression of KDR mRNA | decreases expression | 19638242
|
| D004054 |
Diethylstilbestrol |
Diethylstilbestrol results in increased expression of KDR mRNA | increases expression | 17005392
|
| C045651 |
epigallocatechin gallate |
epigallocatechin gallate results in decreased expression of KDR protein | decreases expression | 17992120
|
| D004958 |
Estradiol |
[Estradiol results in increased secretion of VEGFA protein] which results in increased expression of KDR protein | increases expression|increases secretion | 17289903
|
| D004958 |
Estradiol |
2,3-bis(3'-hydroxybenzyl)butane-1,4-diol inhibits the reaction [Estradiol results in increased expression of KDR protein] | decreases reaction|increases expression | 17289903
|
| D004958 |
Estradiol |
2,3-bis(3'-hydroxybenzyl)butyrolactone inhibits the reaction [Estradiol results in increased expression of KDR protein] | decreases reaction|increases expression | 17289903
|
| D004958 |
Estradiol |
Estradiol results in increased expression of KDR protein | increases expression | 17289903
|
| D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in decreased expression of KDR mRNA | decreases expression | 17557909
|
| D005001 |
Ethionine |
Ethionine affects the expression of KDR mRNA | affects expression | 19483382
|
| D005665 |
Furosemide |
Furosemide results in increased expression of KDR mRNA | increases expression | 16526316
|
| C419708 |
gefitinib |
gefitinib inhibits the reaction [TGFA protein results in decreased expression of KDR mRNA] | decreases expression|decreases reaction | 18424623
|
| D008731 |
Methoxychlor |
Methoxychlor results in increased expression of KDR protein | increases expression | 15503810
|
| D009151 |
Mustard Gas |
IL10 protein affects the reaction [Mustard Gas affects the expression of KDR mRNA] | affects expression|affects reaction | 16173061
|
| D009151 |
Mustard Gas |
Mustard Gas results in decreased expression of KDR mRNA | decreases expression | 16173061
|
| C452423 |
N-(4-bromo-2-fluorophenyl)-6-methoxy-7-((1-methylpiperidin-4-yl)methoxy)quinazolin-4-amine |
N-(4-bromo-2-fluorophenyl)-6-methoxy-7-((1-methylpiperidin-4-yl)methoxy)quinazolin-4-amine results in decreased activity of KDR protein | decreases activity | 16940797 17431108
|
| C064769 |
N-acetylsphingosine |
N-acetylsphingosine results in decreased expression of KDR mRNA | decreases expression | 15741222
|
| C064769 |
N-acetylsphingosine |
sphingosine 1-phosphate inhibits the reaction [N-acetylsphingosine results in decreased expression of KDR mRNA] | decreases expression|decreases reaction | 15741222
|
| D009287 |
Naphthyridines |
Naphthyridines analog results in decreased activity of KDR protein | decreases activity | 16000000
|
| D009853 |
Omeprazole |
Omeprazole affects the expression of KDR mRNA | affects expression | 19483382
|
| C055122 |
orlistat |
orlistat results in decreased expression of KDR protein | decreases expression | 17012255
|
| D010126 |
Ozone |
Ozone results in decreased expression of KDR mRNA | decreases expression | 16330353
|
| C041786 |
palm oil |
palm oil results in increased expression of KDR mRNA | increases expression | 18042831
|
| C410127 |
PCB 180 |
[2,4,4'-trichlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,3',4,4',5-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of KDR mRNA | affects cotreatment|increases expression | 15808785
|
| C073402 |
PD 123319 |
PD 123319 inhibits the reaction [AGT protein results in increased expression of KDR mRNA] | decreases reaction|increases expression | 14638905
|
| D010656 |
Phenylephrine |
Phenylephrine results in decreased expression of KDR mRNA | decreases expression | 18158353
|
| D010671 |
Phenylurea Compounds |
Phenylurea Compounds results in decreased activity of KDR protein | decreases activity | 18343900
|
| C068564 |
phosphatidylbutanol |
KDR protein affects the reaction [VEGFA protein results in increased abundance of phosphatidylbutanol] | affects reaction|increases abundance | 14704231
|
| C006253 |
pirinixic acid |
pirinixic acid results in decreased expression of KDR mRNA | decreases expression | 20059764 18445702
|
| C006253 |
pirinixic acid |
PPARA protein promotes the reaction [pirinixic acid results in decreased expression of KDR mRNA] | decreases expression|increases reaction | 20059764
|
| C006253 |
pirinixic acid |
pirinixic acid affects the expression of KDR mRNA | affects expression | 19483382
|
| D011441 |
Propylthiouracil |
Propylthiouracil affects the expression of KDR mRNA | affects expression | 19483382
|
| C059514 |
resveratrol |
resveratrol results in decreased expression of KDR protein | decreases expression | 17992120
|
| C059514 |
resveratrol |
resveratrol results in increased expression of KDR protein | increases expression | 15905131 16456233
|
| C471405 |
sorafenib |
sorafenib results in decreased activity of KDR protein | decreases activity | 16940797
|
| C060506 |
sphingosine 1-phosphate |
sphingosine 1-phosphate inhibits the reaction [Thalidomide results in decreased expression of KDR mRNA] | decreases expression|decreases reaction | 15741222
|
| C060506 |
sphingosine 1-phosphate |
sphingosine 1-phosphate inhibits the reaction [N-acetylsphingosine results in decreased expression of KDR mRNA] | decreases expression|decreases reaction | 15741222
|
| C060506 |
sphingosine 1-phosphate |
sphingosine 1-phosphate inhibits the reaction [Thalidomide results in decreased expression of KDR mRNA] | decreases expression|decreases reaction | 15741222
|
| D013311 |
Streptozocin |
Streptozocin results in increased expression of KDR mRNA | increases expression | 15643138
|
| D013311 |
Streptozocin |
Streptozocin results in increased expression of KDR protein | increases expression | 15643138
|
| C483044 |
SU 1498 |
SU 1498 results in decreased activity of KDR protein | decreases activity | 15845615 16385078
|
| C116890 |
SU 5416 |
SU 5416 results in decreased activity of KDR protein | decreases activity | 12673719 12649163
|
| C116890 |
SU 5416 |
SU 5416 results in decreased activity of KDR protein | decreases activity | 15788688
|
| C412603 |
SU 6668 |
SU 6668 results in decreased phosphorylation of and results in decreased activity of KDR protein | decreases activity|decreases phosphorylation | 16144927
|
| C412603 |
SU 6668 |
SU 6668 results in decreased activity of KDR protein | decreases activity | 15788688 16132614 15551349 15739567 14760097
|
| D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of KDR mRNA | decreases expression | 20106945
|
| D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin affects the expression of KDR mRNA | affects expression | 16962184
|
| D013792 |
Thalidomide |
SMPD2 protein promotes the reaction [Thalidomide results in decreased expression of KDR mRNA] | decreases expression|increases reaction | 15741222
|
| D013792 |
Thalidomide |
sphingosine 1-phosphate inhibits the reaction [Thalidomide results in decreased expression of KDR mRNA] | decreases expression|decreases reaction | 15741222
|
| D013792 |
Thalidomide |
Thalidomide results in decreased expression of KDR mRNA | decreases expression | 15741222
|
| D013792 |
Thalidomide |
sphingosine 1-phosphate inhibits the reaction [Thalidomide results in decreased expression of KDR mRNA] | decreases expression|decreases reaction | 15741222
|
| D013853 |
Thioacetamide |
Thioacetamide affects the expression of KDR mRNA | affects expression | 19483382
|
| D013893 |
Thiram |
Thiram results in decreased expression of KDR mRNA | decreases expression | 17954590
|
| D014212 |
Tretinoin |
Tretinoin results in increased expression of KDR mRNA | increases expression | 17170094
|
| D014508 |
Urea |
Urea analog results in decreased activity of KDR protein | decreases activity | 16000000
|
| C081489 |
valsartan |
valsartan inhibits the reaction [AGT protein results in increased expression of KDR mRNA] | decreases reaction|increases expression | 15005273
|
| C081489 |
valsartan |
valsartan inhibits the reaction [AGT protein results in increased expression of KDR mRNA] | decreases reaction|increases expression | 14638905
|
| C025643 |
vinclozolin |
vinclozolin affects the expression of KDR mRNA | affects expression | 19015723
|
| D015032 |
Zinc |
Zinc results in decreased expression of KDR mRNA | decreases expression | 17074742
|
| D019287 |
Zinc Sulfate |
Zinc Sulfate results in decreased expression of KDR mRNA | decreases expression | 17074742
|
| Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
|---|
| MESH:D015746 |
Abdominal Pain |
|
SU 5416 |
6.47 | 12673719 |
| MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
6.33 | 11752688 15322242 14514962 |
| MESH:D000014 |
Abnormalities, Drug-Induced |
|
Thalidomide |
6.33 | 8333272 |
| MESH:D000138 |
Acidosis |
|
Zinc Sulfate |
4.18 | 7265320 |
| MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.20 | 17505938 |
| MESH:D000169 |
Acrodermatitis |
|
Zinc |
4.67 | 17202136 17190629 16889938 |
| MESH:D058186 |
Acute Kidney Injury |
|
resveratrol |
3.21 | 16538975 |
| MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
2.45 | 18653653 |
| MESH:D000230 |
Adenocarcinoma |
marker/mechanism |
|
| 21472143 |
| MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
5.52 | 20464547 20127859 |
| MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
5.52 | 11473722 |
| MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
5.52 | 14692618 |
| MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
8.46 | 6695378 |
| MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
8.46 | 6695378 10737359 |
| MESH:D000236 |
Adenoma |
|
resveratrol |
8.46 | 15688382 |
| MESH:D018248 |
Adenoma, Liver Cell |
|
3,4,5,3',4'-pentachlorobiphenyl |
19.00 | 16628245 |
| MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
19.00 | 16434500 17620307 18056438 19052882 17162532 19061943 |
| MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
19.00 | 16434500 |
| MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
19.00 | 16835633 |
| MESH:D019973 |
Alcohol-Related Disorders |
|
Curcumin |
4.34 | 17887948 |
| MESH:D000505 |
Alopecia |
|
Tretinoin |
3.02 | 15955085 |
| MESH:D000544 |
Alzheimer Disease |
|
Copper |
10.04 | 16886094 16325427 16410023 17119284 16962711 16866297 |
| MESH:D000544 |
Alzheimer Disease |
|
Curcumin |
10.04 | 15590663 |
| MESH:D000544 |
Alzheimer Disease |
|
Ozone |
10.04 | 15513908 |
| MESH:D000544 |
Alzheimer Disease |
|
resveratrol |
10.04 | 16162502 16183991 |
| MESH:D000544 |
Alzheimer Disease |
|
Zinc |
10.04 | 16410023 16325427 16580781 17119284 |
| MESH:D000686 |
Amyloidosis |
|
Diethylstilbestrol |
3.79 | 15469931 |
| MESH:D000690 |
Amyotrophic Lateral Sclerosis |
|
Copper |
6.97 | 10694572 |
| MESH:D000690 |
Amyotrophic Lateral Sclerosis |
|
Thalidomide |
6.97 | 16510725 |
| MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.31 | 11748828 |
| MESH:D018798 |
Anemia, Iron-Deficiency |
|
Copper |
4.24 | 16614410 |
| MESH:D000755 |
Anemia, Sickle Cell |
|
Zinc |
4.21 | 16916123 |
| MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.10 | 10982225 |
| MESH:D000860 |
Anoxia |
|
Zinc Sulfate |
4.29 | 7265320 |
| MESH:D001008 |
Anxiety Disorders |
|
vinclozolin |
3.05 | 19015723 |
| MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
3.36 | 19183758 |
| MESH:D001145 |
Arrhythmias, Cardiac |
|
Amiodarone |
7.02 | 18057881 18218290 20041841 |
| MESH:D001145 |
Arrhythmias, Cardiac |
|
Phenylephrine |
7.02 | 17460149 |
| MESH:D001161 |
Arteriosclerosis |
|
Cyclophosphamide |
12.98 | 15014928 |
| MESH:D001161 |
Arteriosclerosis |
|
Dietary Fats |
12.98 | 15238619 |
| MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
12.98 | 11256880 |
| MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
13.52 | 15885639 |
| MESH:D001169 |
Arthritis, Experimental |
|
resveratrol |
13.52 | 17115116 |
| MESH:D001169 |
Arthritis, Experimental |
|
Thalidomide |
13.52 | 9598899 |
| MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
13.52 | 16412693 |
| MESH:D001172 |
Arthritis, Rheumatoid |
|
Curcumin |
6.04 | 16807698 |
| MESH:D001172 |
Arthritis, Rheumatoid |
|
Ozone |
6.04 | 15570426 |
| MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
6.04 | 16292516 |
| MESH:D001249 |
Asthma |
|
epigallocatechin gallate |
11.82 | 16516891 |
| MESH:D001249 |
Asthma |
|
Mustard Gas |
11.82 | 10378619 |
| MESH:D001249 |
Asthma |
|
Ozone |
11.82 | 16373670 17854713 |
| MESH:D001249 |
Asthma |
|
Tretinoin |
11.82 | 16456186 |
| MESH:D001249 |
Asthma |
|
Zinc |
11.82 | 17085522 |
| MESH:D050197 |
Atherosclerosis |
|
Curcumin |
5.33 | 18704882 |
| MESH:D050197 |
Atherosclerosis |
|
resveratrol |
5.33 | 17967414 16873680 |
| MESH:D001281 |
Atrial Fibrillation |
|
Amiodarone |
3.33 | 18651412 19698954 |
| MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.54 | 18445737 |
| MESH:D001327 |
Autoimmune Diseases |
|
Curcumin |
8.75 | 19761891 |
| MESH:D001327 |
Autoimmune Diseases |
|
epigallocatechin gallate |
8.75 | 19761891 |
| MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
3.71 | 16935849 |
| MESH:D001768 |
Blister |
|
Mustard Gas |
4.43 | 19167455 |
| MESH:D001778 |
Blood Coagulation Disorders |
|
Amiodarone |
51.70 | 19483382 |
| MESH:D001778 |
Blood Coagulation Disorders |
|
Benzbromarone |
51.70 | 19483382 |
| MESH:D001778 |
Blood Coagulation Disorders |
|
Clofibrate |
51.70 | 19483382 |
| MESH:D001778 |
Blood Coagulation Disorders |
|
Ethionine |
51.70 | 19483382 |
| MESH:D001778 |
Blood Coagulation Disorders |
|
Omeprazole |
51.70 | 19483382 |
| MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
51.70 | 19483382 |
| MESH:D001778 |
Blood Coagulation Disorders |
|
Propylthiouracil |
51.70 | 19483382 |
| MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
51.70 | 12125929 |
| MESH:D001778 |
Blood Coagulation Disorders |
|
Thioacetamide |
51.70 | 19483382 |
| MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
51.70 | 16206674 16197459 |
| MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.05 | 15340226 |
| MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.26 | 15746008 |
| MESH:D001919 |
Bradycardia |
|
Phenylephrine |
3.82 | 15306635 |
| MESH:D001930 |
Brain Injuries |
|
Zinc |
3.98 | 17109824 |
| MESH:D002545 |
Brain Ischemia |
|
Curcumin |
7.92 | 16770732 |
| MESH:D002545 |
Brain Ischemia |
|
resveratrol |
7.92 | 17600658 |
| MESH:D001932 |
Brain Neoplasms |
|
Copper |
11.42 | 17079463 |
| MESH:D001932 |
Brain Neoplasms |
|
Curcumin |
11.42 | 17596214 |
| MESH:D001932 |
Brain Neoplasms |
|
SU 6668 |
11.42 | 15739567 |
| MESH:D001943 |
Breast Neoplasms |
marker/mechanism |
|
| 20135347 |
| MESH:D001943 |
Breast Neoplasms |
|
2,3-bis(3'-hydroxybenzyl)butane-1,4-diol |
12.12 | 17289903 |
| MESH:D001943 |
Breast Neoplasms |
|
2,3-bis(3'-hydroxybenzyl)butyrolactone |
12.12 | 17289903 |
| MESH:D001943 |
Breast Neoplasms |
|
2-methoxyestradiol-3,17-bis-O,O-sulfamate |
12.12 | 15862969 14970876 12711013 17426705 17957467 12711022 |
| MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
12.12 | 20146248 17474063 |
| MESH:D001943 |
Breast Neoplasms |
|
Copper |
12.12 | 15986119 17079463 |
| MESH:D001943 |
Breast Neoplasms |
|
Curcumin |
12.12 | 16243823 19250217 18462866 18593918 |
| MESH:D001943 |
Breast Neoplasms |
|
Cyclophosphamide |
12.12 | 15093573 18234424 17020986 17388661 18323546 15136595 12006526 16978400 11325840 |
| MESH:D001943 |
Breast Neoplasms |
|
deguelin |
12.12 | 18593368 17035597 |
| MESH:D001943 |
Breast Neoplasms |
|
Dietary Fats |
12.12 | 20435547 |
| MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
12.12 | 17474063 |
| MESH:D001943 |
Breast Neoplasms |
|
Diethylstilbestrol |
12.12 | 15324884 17129689 |
| MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
12.12 | 17018787 12948864 17289903 18497071 19861407 16675129 14630087 17261762 |
| MESH:D001943 |
Breast Neoplasms |
|
resveratrol |
12.12 | 17651959 16393696 17534123 |
| MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
12.12 | 20435547 |
| MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
12.12 | 16166294 16443354 16873071 |
| MESH:D016535 |
Bronchial Hyperreactivity |
|
Ozone |
3.09 | 17626835 18417511 19059883 15516495 16777450 18315731 14754758 |
| MESH:D001989 |
Bronchiolitis Obliterans |
|
Mustard Gas |
4.43 | 15286001 |
| MESH:D029481 |
Bronchitis, Chronic |
|
Mustard Gas |
4.24 | 17687719 10378619 |
| MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
3.86 | 16813970 |
| MESH:D019121 |
Burkholderia Infections |
|
orlistat |
5.90 | 17874328 |
| MESH:D002100 |
Cachexia |
|
Ozone |
4.01 | 16183385 |
| MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
3.74 | 16111702 |
| MESH:D002276 |
Carcinoid Tumor |
|
Streptozocin |
4.86 | 16051944 |
| MESH:D002277 |
Carcinoma |
|
Curcumin |
6.32 | 18593918 |
| MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
6.32 | 16835633 |
| MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
4.42 | 16168501 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
27.59 | 16705839 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
27.59 | 16705839 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
27.59 | 3084413 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Benzbromarone |
27.59 | 1701930 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Cyclophosphamide |
27.59 | 19701751 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
deguelin |
27.59 | 18575727 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
27.59 | 16502159 18785209 16288022 19418558 16935385 20935162 17978847 20101231 17055752 17162532 19052882 16807293 17173139 19107877 16878318 19383236 10672840 16681979 18788625 20524982 16569478 20432363 20514400 18494052 19539802 18056438 18506893 18691550 17138121 16540662 20727157 11831363 19919837 20084675 20214788 19208518 19171122 18971187 18393292 16698587 17761372 19394651 3084413 18978308 19701751 10737359 16328049 19519916 18210153 17428255 3581430 18665156 21159647 16830150 19822196 20007298 19335982 20512989 16779866 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylstilbestrol |
27.59 | 15948411 16924424 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
27.59 | 16924424 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
resveratrol |
27.59 | 19321006 16227395 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Thalidomide |
27.59 | 16313753 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Thioacetamide |
27.59 | 17997003 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
27.59 | 1917145 |
| MESH:D018827 |
Carcinoma, Lewis Lung |
|
Cyclophosphamide |
9.08 | 16152834 |
| MESH:D018827 |
Carcinoma, Lewis Lung |
|
resveratrol |
9.08 | 16675471 |
| MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
Curcumin |
5.05 | 18414057 |
| MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
gefitinib |
5.05 | 17290066 20005069 19233551 15496427 16230376 18347146 |
| MESH:D002292 |
Carcinoma, Renal Cell |
|
Cyclophosphamide |
3.14 | 16201981 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
Acetylcysteine |
14.37 | 17015178 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
14.37 | 20419170 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
Curcumin |
14.37 | 18462866 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
resveratrol |
14.37 | 16227395 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
14.37 | 16096774 16051514 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
Zinc |
14.37 | 16543248 |
| MESH:D006332 |
Cardiomegaly |
|
Copper |
12.67 | 17327471 |
| MESH:D006332 |
Cardiomegaly |
|
Phenylephrine |
12.67 | 17124262 17287366 11179087 11754973 15728586 16170337 |
| MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
12.67 | 18850075 18670907 16120746 |
| MESH:D006332 |
Cardiomegaly |
|
valsartan |
12.67 | 19597038 |
| MESH:D009202 |
Cardiomyopathies |
|
valsartan |
3.93 | 16247790 |
| MESH:D002311 |
Cardiomyopathy, Dilated |
|
Amiodarone |
2.59 | 19225199 15710769 |
| MESH:D002318 |
Cardiovascular Diseases |
|
resveratrol |
9.31 | 15458977 |
| MESH:D002318 |
Cardiovascular Diseases |
|
valsartan |
9.31 | 11230374 |
| MESH:D002318 |
Cardiovascular Diseases |
|
Zinc |
9.31 | 16936243 |
| MESH:D002341 |
Carotid Artery Thrombosis |
|
Amiodarone |
4.36 | 18974383 |
| MESH:D002386 |
Cataract |
|
Acetaminophen |
5.64 | 10977129 |
| MESH:D002386 |
Cataract |
|
Tretinoin |
5.64 | 17460283 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
19.48 | 6135515 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
Acetylcysteine |
19.48 | 18226522 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
Clofibrate |
19.48 | 1399818 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
19.48 | 12371664 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
19.48 | 17174075 7505956 21159647 2727394 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
19.48 | 18566989 |
| MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
3.86 | 16129372 |
| MESH:D002637 |
Chest Pain |
|
Omeprazole |
4.37 | 15447763 |
| MESH:D018281 |
Cholangiocarcinoma |
|
3,4,5,3',4'-pentachlorobiphenyl |
23.69 | 16628245 |
| MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
23.69 | 19052882 |
| MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
23.69 | 16835633 |
| MESH:D018281 |
Cholangiocarcinoma |
|
Thalidomide |
23.69 | 18291259 |
| MESH:D018281 |
Cholangiocarcinoma |
|
Thioacetamide |
23.69 | 18291259 |
| MESH:D002779 |
Cholestasis |
|
Cyclosporine |
10.08 | 19486331 |
| MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
10.08 | 16105132 11677210 16919318 17110522 17681005 17333356 15861022 |
| MESH:D002779 |
Cholestasis |
|
pirinixic acid |
10.08 | 19176532 |
| MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
4.42 | 16461808 |
| MESH:D002916 |
Chylothorax |
|
orlistat |
5.90 | 17003701 |
| MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
4.53 | 16354765 8697196 12621046 15340226 15668235 |
| MESH:D002972 |
Cleft Palate |
|
Tretinoin |
4.53 | 9407595 |
| MESH:D003092 |
Colitis |
|
Curcumin |
17.13 | 16804969 16782535 18200517 |
| MESH:D003092 |
Colitis |
|
resveratrol |
17.13 | 16474422 |
| MESH:D003092 |
Colitis |
|
Thalidomide |
17.13 | 16680017 |
| MESH:D003092 |
Colitis |
|
Tretinoin |
17.13 | 17035595 |
| MESH:D003103 |
Coloboma |
|
Curcumin |
3.89 | 18809619 |
| MESH:D003110 |
Colonic Neoplasms |
|
Curcumin |
3.38 | 19359593 16340194 |
| MESH:D003110 |
Colonic Neoplasms |
|
resveratrol |
3.38 | 16338953 |
| MESH:D015179 |
Colorectal Neoplasms |
|
Azacitidine |
3.22 | 19934284 |
| MESH:D015179 |
Colorectal Neoplasms |
|
gefitinib |
3.22 | 17594712 |
| MESH:D015179 |
Colorectal Neoplasms |
|
resveratrol |
3.22 | 16550006 |
| MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.44 | 17141729 14669216 |
| MESH:D016510 |
Corneal Neovascularization |
|
Curcumin |
10.25 | 18497527 |
| MESH:D016510 |
Corneal Neovascularization |
|
Thalidomide |
10.25 | 9301478 |
| MESH:D003324 |
Coronary Artery Disease |
|
valsartan |
3.58 | 17719468 |
| MESH:D003327 |
Coronary Disease |
|
resveratrol |
3.25 | 16507316 |
| MESH:D003384 |
Coxsackievirus Infections |
|
valsartan |
5.11 | 20392896 |
| MESH:D003389 |
Cranial Nerve Diseases |
|
Thalidomide |
5.56 | 9200351 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
3,4,5,3',4'-pentachlorobiphenyl |
6.03 | 17686920 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
6.03 | 10048152 15322242 20055451 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
Thalidomide |
6.03 | 9200351 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
6.03 | 9125849 16925845 9211117 9142499 8800419 10589399 9664655 17551590 9224671 14991402 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
Zinc |
6.03 | 19302082 |
| MESH:D003424 |
Crohn Disease |
|
Thalidomide |
3.76 | 16078585 |
| MESH:D003456 |
Cryptorchidism |
|
Diethylstilbestrol |
9.07 | 16002989 12952375 |
| MESH:D003456 |
Cryptorchidism |
|
vinclozolin |
9.07 | 14966744 |
| MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
8.54 | 18551238 |
| MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
8.54 | 18551238 |
| MESH:D003550 |
Cystic Fibrosis |
|
Acetylcysteine |
3.75 | 19747007 |
| MESH:D003556 |
Cystitis |
|
Cyclophosphamide |
4.25 | 12161096 16413132 11948286 12388444 16651033 18372110 18295254 18093676 18710439 18433785 16989017 12913760 18483878 10498854 10700343 15276878 17010015 15643279 17979934 16614059 |
| MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.03 | 18249437 |
| MESH:D002658 |
Developmental Disabilities |
|
2,3',4,4',5-pentachlorobiphenyl |
4.93 | 19647017 |
| MESH:D048909 |
Diabetes Complications |
|
orlistat |
5.10 | 19207292 |
| MESH:D003920 |
Diabetes Mellitus |
|
Streptozocin |
7.67 | 16285004 |
| MESH:D003920 |
Diabetes Mellitus |
|
Zinc |
7.67 | 16479319 |
| MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Cyclophosphamide |
14.98 | 10990075 11751995 15331540 |
| MESH:D003921 |
Diabetes Mellitus, Experimental |
|
resveratrol |
14.98 | 16873680 |
| MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Streptozocin |
14.98 | 7637645 12093613 15862027 17442507 2177838 19960420 19496084 19298542 16684804 18715473 12446591 12644472 18603373 6379147 16286809 11260395 15298345 12083368 11055810 15831366 1374869 8740154 17874149 19586609 |
| MESH:D003921 |
Diabetes Mellitus, Experimental |
|
valsartan |
14.98 | 11508273 |
| MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Cyclophosphamide |
5.10 | 18772604 |
| MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Streptozocin |
5.10 | 18603373 |
| MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Curcumin |
10.97 | 18403477 |
| MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
10.97 | 20387270 |
| MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
epigallocatechin gallate |
10.97 | 16988119 |
| MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Streptozocin |
10.97 | 19586609 19647726 |
| MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
10.97 | 17107852 |
| MESH:D058065 |
Diabetic Cardiomyopathies |
|
Streptozocin |
5.00 | 16025228 |
| MESH:D003928 |
Diabetic Nephropathies |
marker/mechanism |
|
| 18630688 |
| MESH:D003928 |
Diabetic Nephropathies |
|
Curcumin |
21.54 | 18204486 |
| MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
21.54 | 19279558 |
| MESH:D003928 |
Diabetic Nephropathies |
|
resveratrol |
21.54 | 16286809 |
| MESH:D003928 |
Diabetic Nephropathies |
|
Streptozocin |
21.54 | 19682444 19960420 |
| MESH:D003928 |
Diabetic Nephropathies |
|
valsartan |
21.54 | 11427623 18630688 |
| MESH:D003930 |
Diabetic Retinopathy |
|
Streptozocin |
4.73 | 17662242 |
| MESH:D003967 |
Diarrhea |
|
orlistat |
6.94 | 20002075 |
| MESH:D003967 |
Diarrhea |
|
SU 5416 |
6.94 | 12673719 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
17.10 | 21346803 18551238 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
17.10 | 18551238 21346803 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
17.10 | 17562736 18071297 16393943 11461765 12540782 19416960 12392966 17906064 19420014 17522070 14550746 14725611 11529661 11421492 10663392 16781746 12594235 11287661 19164858 19739265 18713872 15968718 19370779 12705907 16485898 12958197 12153990 10915739 11739529 16227642 11743745 19085960 15619225 11834606 2444490 16081117 16177239 14986274 19923254 16109766 10774834 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetylcysteine |
17.10 | 11287661 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Amiodarone |
17.10 | 18218290 15265979 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
17.10 | 19107877 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
17.10 | 20420201 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Thioacetamide |
17.10 | 12963478 |
| MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
3.36 | 19426721 |
| MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.20 | 11462148 |
| MESH:D004381 |
Duodenal Ulcer |
|
Curcumin |
7.21 | 17351913 |
| MESH:D004381 |
Duodenal Ulcer |
|
Omeprazole |
7.21 | 21218061 16613094 15991576 17151854 |
| MESH:D050171 |
Dyslipidemias |
|
Clofibrate |
6.98 | 16707586 |
| MESH:D050171 |
Dyslipidemias |
|
Dietary Fats |
6.98 | 18367378 |
| MESH:D004417 |
Dyspnea |
|
Furosemide |
8.76 | 16935035 |
| MESH:D004417 |
Dyspnea |
|
SU 5416 |
8.76 | 12673719 12649163 |
| MESH:D004487 |
Edema |
|
bisindolylmaleimide I |
22.74 | 8273558 |
| MESH:D004487 |
Edema |
|
demethoxycurcumin |
22.74 | 18449507 |
| MESH:D004487 |
Edema |
|
Furosemide |
22.74 | 11834646 |
| MESH:D004487 |
Edema |
|
Mustard Gas |
22.74 | 9260866 11402378 11428631 11428647 |
| MESH:D004487 |
Edema |
|
pirinixic acid |
22.74 | 12083418 |
| MESH:D004487 |
Edema |
|
resveratrol |
22.74 | 8985016 |
| MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
22.74 | 12711302 11000095 |
| MESH:D004489 |
Edema, Cardiac |
|
3,4,5,3',4'-pentachlorobiphenyl |
16.83 | 17686920 |
| MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
16.83 | 18230668 15322242 16714409 |
| MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
16.83 | 18230668 |
| MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
6.84 | 12538720 |
| MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
resveratrol |
6.84 | 17872969 |
| MESH:D004714 |
Endometrial Hyperplasia |
|
Diethylstilbestrol |
3.97 | 16402032 |
| MESH:D016889 |
Endometrial Neoplasms |
|
Diethylstilbestrol |
9.50 | 16804899 15700306 |
| MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
9.50 | 18566989 11473722 19148513 |
| MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
9.50 | 16569247 |
| MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.39 | 10568697 9294722 |
| MESH:D020345 |
Enterocolitis, Necrotizing |
|
resveratrol |
4.14 | 17923197 |
| MESH:D004802 |
Eosinophilia |
|
Cyclophosphamide |
3.52 | 11006010 |
| MESH:D004890 |
Erythema |
|
Mustard Gas |
4.43 | 9357497 |
| MESH:D004892 |
Erythema Multiforme |
|
Thiram |
5.91 | 16750123 |
| MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
4.38 | 16302075 |
| MESH:D004938 |
Esophageal Neoplasms |
marker/mechanism |
|
| 21472143 |
| MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
3.80 | 16530937 |
| MESH:D004938 |
Esophageal Neoplasms |
|
Zinc |
3.80 | 16543248 |
| MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
6.95 | 11564622 |
| MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
6.95 | 16938888 9664655 |
| MESH:D005221 |
Fatigue |
|
SU 5416 |
5.66 | 12673719 12649163 |
| MESH:D005218 |
Fat Necrosis |
|
Thioacetamide |
4.98 | 16456712 |
| MESH:D005234 |
Fatty Liver |
|
Amiodarone |
31.91 | 14986274 |
| MESH:D005234 |
Fatty Liver |
|
Clofibrate |
31.91 | 19224547 |
| MESH:D005234 |
Fatty Liver |
|
Curcumin |
31.91 | 19297423 |
| MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
31.91 | 19224547 |
| MESH:D005234 |
Fatty Liver |
|
Dietary Fats |
31.91 | 17967931 19551842 19004024 18296743 |
| MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
31.91 | 21071580 20387270 |
| MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
31.91 | 15345470 |
| MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
31.91 | 20131406 19236843 |
| MESH:D052776 |
Female Urogenital Diseases |
|
Diethylstilbestrol |
3.17 | 16534752 16513791 15751030 16611131 16002989 |
| MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
2.75 | 11858732 |
| MESH:D005355 |
Fibrosis |
|
Curcumin |
25.42 | 18705752 |
| MESH:D005355 |
Fibrosis |
|
Cyclosporine |
25.42 | 12168785 12639820 |
| MESH:D005355 |
Fibrosis |
|
Dietary Fats |
25.42 | 18296743 |
| MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
25.42 | 20067830 |
| MESH:D005355 |
Fibrosis |
|
Tretinoin |
25.42 | 17994277 |
| MESH:D005355 |
Fibrosis |
|
valsartan |
25.42 | 16893502 |
| MESH:D005414 |
Flatulence |
|
orlistat |
5.90 | 20002075 |
| MESH:D005756 |
Gastritis |
|
Acetaminophen |
8.71 | 16983495 |
| MESH:D005756 |
Gastritis |
|
Zinc |
8.71 | 17241300 |
| MESH:D005770 |
Gastrointestinal Neoplasms |
|
Curcumin |
3.98 | 18462866 |
| MESH:D030342 |
Genetic Diseases, Inborn |
|
vinclozolin |
4.21 | 16973722 |
| MESH:D005832 |
Genital Diseases, Male |
|
vinclozolin |
4.56 | 16417039 |
| MESH:D005833 |
Genital Neoplasms, Female |
|
Diethylstilbestrol |
4.22 | 16452187 |
| MESH:D005871 |
Giant Lymph Node Hyperplasia |
|
Thalidomide |
5.56 | 12701121 |
| MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
3.49 | 8708960 |
| MESH:D005909 |
Glioblastoma |
|
Curcumin |
5.59 | 17596214 |
| MESH:D005909 |
Glioblastoma |
|
Tretinoin |
5.59 | 17312396 |
| MESH:D005910 |
Glioma |
|
SU 6668 |
6.12 | 15739567 |
| MESH:D005910 |
Glioma |
|
Thalidomide |
6.12 | 16327979 |
| MESH:D018316 |
Gliosarcoma |
|
Cyclophosphamide |
4.79 | 11389073 |
| MESH:D015432 |
Glomerulonephritis, Membranoproliferative |
|
valsartan |
4.85 | 16928621 |
| MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
3.85 | 10696789 |
| MESH:D006086 |
Graft vs Host Disease |
|
Cyclophosphamide |
4.32 | 16376943 11014644 15172196 |
| MESH:D006130 |
Growth Disorders |
|
Zinc |
3.45 | 17217573 |
| MESH:D006261 |
Headache |
|
SU 5416 |
5.32 | 12649163 12673719 |
| MESH:D006258 |
Head and Neck Neoplasms |
|
Curcumin |
6.14 | 18462866 18829502 |
| MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
6.14 | 16096774 |
| MESH:D034381 |
Hearing Loss |
|
Furosemide |
4.20 | 17868369 |
| MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
4.42 | 16084493 |
| MESH:D006330 |
Heart Defects, Congenital |
|
3,4,3',4'-tetrachlorobiphenyl |
16.43 | 11294989 |
| MESH:D006330 |
Heart Defects, Congenital |
|
3,4,5,3',4'-pentachlorobiphenyl |
16.43 | 17686920 20471113 |
| MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
16.43 | 20471113 |
| MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
16.43 | 11294989 10048152 |
| MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
16.43 | 14991402 9664655 |
| MESH:D006331 |
Heart Diseases |
|
Streptozocin |
3.75 | 12093613 |
| MESH:D006333 |
Heart Failure |
|
Furosemide |
12.94 | 12660669 16011733 16845234 |
| MESH:D006333 |
Heart Failure |
|
pirinixic acid |
12.94 | 20558911 |
| MESH:D006333 |
Heart Failure |
|
valsartan |
12.94 | 19027736 |
| MESH:D006333 |
Heart Failure |
|
Zinc |
12.94 | 17162251 |
| MESH:D006335 |
Heart Injuries |
|
Zinc |
5.03 | 17074742 |
| MESH:D016481 |
Helicobacter Infections |
|
Zinc |
3.86 | 17241300 |
| MESH:C535860 |
Hemangioma, capillary infantile |
marker/mechanism |
|
| |
| MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
3.69 | 15720958 |
| MESH:D006467 |
Hemophilia A |
|
Cyclophosphamide |
4.58 | 11918545 |
| MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
2.68 | 11000095 |
| MESH:D006501 |
Hepatic Encephalopathy |
|
Thioacetamide |
3.91 | 18665440 17276928 15929193 |
| MESH:D006504 |
Hepatic Veno-Occlusive Disease |
|
Cyclophosphamide |
4.79 | 14986274 |
| MESH:D006505 |
Hepatitis |
|
Thioacetamide |
3.53 | 16456712 |
| MESH:D006521 |
Hepatitis, Chronic |
|
Copper |
4.54 | 17338147 |
| MESH:D006527 |
Hepatolenticular Degeneration |
|
Copper |
14.56 | 17276780 19888908 17109627 16607473 17182432 |
| MESH:D006527 |
Hepatolenticular Degeneration |
|
Zinc |
14.56 | 17276780 |
| MESH:D006527 |
Hepatolenticular Degeneration |
|
Zinc Sulfate |
14.56 | 17063115 |
| MESH:D006529 |
Hepatomegaly |
|
Amiodarone |
10.35 | 15265979 |
| MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
10.35 | 19176532 16221962 19772884 18467677 |
| MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
10.35 | 15340226 12621046 16120746 |
| MESH:D015417 |
Hereditary Sensory and Motor Neuropathy |
|
Curcumin |
4.33 | 17701891 |
| MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.29 | 15709030 |
| MESH:D006561 |
Herpes Simplex |
|
resveratrol |
3.46 | 16876885 |
| MESH:D006689 |
Hodgkin Disease |
|
Cyclophosphamide |
3.19 | 17606976 16135485 |
| MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.02 | 17088409 |
| MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.30 | 15340226 16354765 16959395 18606429 8697196 |
| MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
5.67 | 16870215 |
| MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
5.67 | 16870215 |
| MESH:D006934 |
Hypercalcemia |
|
Furosemide |
4.41 | 17652376 |
| MESH:D053565 |
Hypercalciuria |
|
Furosemide |
4.92 | 17652376 |
| MESH:D006937 |
Hypercholesterolemia |
|
Amiodarone |
16.46 | 9751232 8137927 |
| MESH:D006937 |
Hypercholesterolemia |
|
Curcumin |
16.46 | 18704882 |
| MESH:D006937 |
Hypercholesterolemia |
|
Dietary Fats |
16.46 | 21332399 |
| MESH:D006937 |
Hypercholesterolemia |
|
resveratrol |
16.46 | 17188708 |
| MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
3.86 | 16778211 |
| MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
2.55 | 20558911 |
| MESH:D006949 |
Hyperlipidemias |
|
Dietary Fats |
11.76 | 21332399 |
| MESH:D006949 |
Hyperlipidemias |
|
orlistat |
11.76 | 21332399 |
| MESH:D006949 |
Hyperlipidemias |
|
resveratrol |
11.76 | 16873680 |
| MESH:D006962 |
Hyperparathyroidism, Secondary |
|
Furosemide |
5.13 | 15086907 |
| MESH:D006965 |
Hyperplasia |
|
Diethylstilbestrol |
3.73 | 12960047 14722030 |
| MESH:D006973 |
Hypertension |
|
Cyclosporine |
9.58 | 10903974 |
| MESH:D006973 |
Hypertension |
|
Phenylephrine |
9.58 | 12717712 8949925 |
| MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
9.58 | 18670907 18850075 |
| MESH:D006973 |
Hypertension |
|
valsartan |
9.58 | 10903974 18344623 16475468 20102058 11427623 18390891 12692753 12850387 |
| MESH:D006974 |
Hypertension, Malignant |
|
valsartan |
5.67 | 11560862 |
| MESH:D046110 |
Hypertension, Pregnancy-Induced |
|
Furosemide |
4.57 | 16612254 |
| MESH:D006976 |
Hypertension, Pulmonary |
|
gefitinib |
4.15 | 18424623 |
| MESH:D006984 |
Hypertrophy |
|
Phenylephrine |
3.90 | 18502941 12791704 |
| MESH:D017379 |
Hypertrophy, Left Ventricular |
|
resveratrol |
3.66 | 17488730 |
| MESH:D017380 |
Hypertrophy, Right Ventricular |
|
gefitinib |
5.51 | 18424623 |
| MESH:C537153 |
Hypomagnesemia primary |
|
Furosemide |
4.92 | 11041285 |
| MESH:D007019 |
Hypoproteinemia |
|
Furosemide |
5.13 | 16096441 |
| MESH:D007021 |
Hypospadias |
|
Diethylstilbestrol |
8.89 | 16002989 |
| MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
8.89 | 16945680 16569931 |
| MESH:D007022 |
Hypotension |
|
Furosemide |
7.46 | 11041285 |
| MESH:D007022 |
Hypotension |
|
Zinc Sulfate |
7.46 | 7265320 |
| MESH:D007024 |
Hypotension, Orthostatic |
|
Furosemide |
4.68 | 15811171 |
| MESH:D007037 |
Hypothyroidism |
|
Amiodarone |
9.25 | 18020914 17991464 |
| MESH:D007037 |
Hypothyroidism |
|
Propylthiouracil |
9.25 | 8137927 18031379 |
| MESH:D007154 |
Immune System Diseases |
|
Cyclophosphamide |
4.59 | 16076520 |
| MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
resveratrol |
3.94 | 17600658 |
| MESH:D007246 |
Infertility |
|
Diethylstilbestrol |
8.98 | 15036965 |
| MESH:D007246 |
Infertility |
|
Thiram |
8.98 | 6420938 |
| MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
2.79 | 12013081 |
| MESH:D007248 |
Infertility, Male |
|
2,2',3',4,4',5-hexachlorobiphenyl |
15.66 | 12948891 |
| MESH:D007248 |
Infertility, Male |
|
Cyclophosphamide |
15.66 | 16517039 7193160 |
| MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
15.66 | 17937319 |
| MESH:D007248 |
Infertility, Male |
|
Methoxychlor |
15.66 | 11955947 16467254 |
| MESH:D007248 |
Infertility, Male |
|
vinclozolin |
15.66 | 16467254 |
| MESH:D007249 |
Inflammation |
|
bisindolylmaleimide I |
20.99 | 8273558 |
| MESH:D007249 |
Inflammation |
|
Curcumin |
20.99 | 18403477 17151092 16956363 |
| MESH:D007249 |
Inflammation |
|
Dietary Fats |
20.99 | 20412841 |
| MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
20.99 | 18785209 |
| MESH:D007249 |
Inflammation |
|
Mustard Gas |
20.99 | 17524151 11402378 9260866 9357497 11428620 16001271 8975870 11428647 11428631 |
| MESH:D007249 |
Inflammation |
|
resveratrol |
20.99 | 16366677 |
| MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
20.99 | 12878042 12200463 |
| MESH:D007249 |
Inflammation |
|
Thalidomide |
20.99 | 16134734 |
| MESH:D015212 |
Inflammatory Bowel Diseases |
|
Curcumin |
2.86 | 18596194 18200517 |
| MESH:D007251 |
Influenza, Human |
|
resveratrol |
3.81 | 16624496 |
| MESH:D007333 |
Insulin Resistance |
|
Dietary Fats |
13.48 | 18457598 11836018 |
| MESH:D007333 |
Insulin Resistance |
|
Estradiol |
13.48 | 16393666 16627594 |
| MESH:D007333 |
Insulin Resistance |
|
orlistat |
13.48 | 17201808 |
| MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
13.48 | 16306350 |
| MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.06 | 17994277 |
| MESH:D007414 |
Intestinal Neoplasms |
|
Curcumin |
3.58 | 10783313 |
| MESH:D007511 |
Ischemia |
|
Zinc |
3.92 | 16584753 |
| MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
7.75 | 16580747 |
| MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
7.75 | 15992940 17551590 |
| MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
3.70 | 15604871 |
| MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
21.69 | 12587719 15629191 |
| MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
21.69 | 8314463 10903974 18776723 |
| MESH:D007674 |
Kidney Diseases |
|
Estradiol |
21.69 | 15618244 |
| MESH:D007674 |
Kidney Diseases |
|
Furosemide |
21.69 | 11041285 |
| MESH:D007674 |
Kidney Diseases |
|
Streptozocin |
21.69 | 12093613 |
| MESH:D007674 |
Kidney Diseases |
|
valsartan |
21.69 | 16893502 12164870 10903974 |
| MESH:D007674 |
Kidney Diseases |
|
Zinc |
21.69 | 16960431 |
| MESH:C531755 |
Kidney disorder involving deposition of calcium and oxalate or phosphate in the renal tubules |
|
orlistat |
5.90 | 17185156 |
| MESH:D007676 |
Kidney Failure, Chronic |
|
Copper |
8.27 | 16518626 |
| MESH:D007676 |
Kidney Failure, Chronic |
|
Zinc |
8.27 | 16518626 |
| MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
21.33 | 16705839 |
| MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
21.33 | 16705839 |
| MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
21.33 | 12371664 |
| MESH:D007680 |
Kidney Neoplasms |
|
Diethylstilbestrol |
21.33 | 15003126 14681315 16762066 |
| MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
21.33 | 15610895 |
| MESH:D007680 |
Kidney Neoplasms |
|
gefitinib |
21.33 | 18625569 |
| MESH:D007859 |
Learning Disorders |
|
Copper |
7.66 | 17134702 |
| MESH:D007859 |
Learning Disorders |
|
Diethylstilbestrol |
7.66 | 17184923 |
| MESH:D007889 |
Leiomyoma |
|
Curcumin |
3.90 | 18555241 |
| MESH:D016773 |
Leishmaniasis, Cutaneous |
|
Omeprazole |
6.86 | 19248655 |
| MESH:D016773 |
Leishmaniasis, Cutaneous |
|
Zinc Sulfate |
6.86 | 15237267 |
| MESH:D007898 |
Leishmaniasis, Visceral |
|
Thalidomide |
3.77 | 16514283 |
| MESH:D007938 |
Leukemia |
|
Azacitidine |
11.57 | 19148494 |
| MESH:D007938 |
Leukemia |
|
Curcumin |
11.57 | 18462866 |
| MESH:D007938 |
Leukemia |
|
Cyclophosphamide |
11.57 | 10602166 |
| MESH:D007938 |
Leukemia |
|
Tretinoin |
11.57 | 17143497 |
| MESH:D015451 |
Leukemia, Lymphocytic, Chronic, B-Cell |
|
Cyclophosphamide |
3.13 | 17802794 17008537 17296974 18172266 17658394 18587576 |
| MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
Curcumin |
3.55 | 16106398 |
| MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
Cyclophosphamide |
3.53 | 10373061 |
| MESH:D007951 |
Leukemia, Myeloid |
|
Azacitidine |
7.61 | 19077051 |
| MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
7.61 | 16932348 19285840 16482212 |
| MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Azacitidine |
7.29 | 17596541 18720364 |
| MESH:D015470 |
Leukemia, Myeloid, Acute |
|
SU 5416 |
7.29 | 12649163 |
| MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Thalidomide |
7.29 | 18720364 |
| MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
7.29 | 19850784 16294345 17596541 |
| MESH:D054429 |
Leukemia, Myelomonocytic, Juvenile |
|
Azacitidine |
4.51 | 19299654 |
| MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
resveratrol |
6.05 | 16087638 |
| MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
6.05 | 16891316 17506722 17712046 16766008 17649720 19029980 17107899 19035177 16788101 16140955 17339181 16935935 19642359 17301526 17294898 16331271 16823087 15748426 19075265 12679006 9834237 17368321 17361223 17217047 19225113 |
| MESH:D015458 |
Leukemia, T-Cell |
|
Curcumin |
4.07 | 16106398 |
| MESH:D007970 |
Leukopenia |
|
Cyclophosphamide |
4.24 | 11830472 10052129 |
| MESH:D007984 |
Leydig Cell Tumor |
|
vinclozolin |
4.00 | 16417039 |
| MESH:D017880 |
Limb Deformities, Congenital |
|
Thalidomide |
6.72 | 10473037 |
| MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
6.72 | 9224671 |
| MESH:D008064 |
Lipidoses |
|
Amiodarone |
2.97 | 15342952 17567588 |
| MESH:D008103 |
Liver Cirrhosis |
|
Dietary Fats |
12.15 | 18296743 |
| MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
12.15 | 18665156 18407596 20032147 18522880 19638242 |
| MESH:D008103 |
Liver Cirrhosis |
|
orlistat |
12.15 | 17404856 |
| MESH:D008103 |
Liver Cirrhosis |
|
Thalidomide |
12.15 | 16943688 17174718 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Curcumin |
12.83 | 18006644 18705752 17355460 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
epigallocatechin gallate |
12.83 | 17481882 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
12.83 | 14716833 14659978 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
12.83 | 15474484 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
12.83 | 12878042 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Thalidomide |
12.83 | 15465738 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Thioacetamide |
12.83 | 12891558 15316131 14739098 18295389 10677585 18031379 17050028 17355460 15362042 18458672 15334695 15078482 12679928 18380797 12175628 15095483 15465738 11682029 16489207 15075984 16097051 18416461 15288473 16126171 16098781 11172339 17127702 15716488 12085344 18032466 18615449 15158331 18263696 17629604 18606216 11481614 16511523 16343077 12557150 17292413 18395095 15474484 16248980 15288472 12531686 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
12.83 | 18397230 16248980 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
valsartan |
12.83 | 16872305 15619341 15504291 |
| MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
7.26 | 12969438 11587558 19460945 16611625 19784758 16610002 19014921 12587719 |
| MESH:D008107 |
Liver Diseases |
|
Curcumin |
7.26 | 16956363 |
| MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
7.26 | 17034775 |
| MESH:D008107 |
Liver Diseases |
|
Thioacetamide |
7.26 | 18374380 15158337 16337175 |
| MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
7.51 | 17185352 16871587 |
| MESH:D017114 |
Liver Failure, Acute |
|
Thioacetamide |
7.51 | 15633222 12479984 15313186 17276928 |
| MESH:D008113 |
Liver Neoplasms |
|
2,4,5,2',4',5'-hexachlorobiphenyl |
26.75 | 16835634 18644402 |
| MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
26.75 | 7678174 |
| MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
26.75 | 20195826 21137059 |
| MESH:D008113 |
Liver Neoplasms |
|
Clofibric Acid |
26.75 | 17602206 |
| MESH:D008113 |
Liver Neoplasms |
|
Copper |
26.75 | 20302851 |
| MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
26.75 | 20501860 19638242 20118626 19426721 15885732 18977376 18978307 18648771 19256749 12112319 19996281 19254457 21167192 19690152 2862719 12771043 20405173 18644402 20492335 20137499 21071580 20452335 10737359 20101389 20583210 19499222 19255062 18754104 2422723 21278145 19427195 19812893 19090486 15175105 9163691 19294768 19850985 19833225 16942905 19073162 20434301 21047994 19642983 19551842 |
| MESH:D008113 |
Liver Neoplasms |
|
Diethylstilbestrol |
26.75 | 16712894 15890375 |
| MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
26.75 | 15890375 20007298 16377806 |
| MESH:D008113 |
Liver Neoplasms |
|
resveratrol |
26.75 | 19812893 19073162 20405173 19321006 |
| MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
26.75 | 16984957 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
6.93 | 2876784 6135515 2876786 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
6.93 | 19126423 16267830 17174075 18544905 21159647 19539802 19519916 18079962 18308698 18093689 18164116 19009564 9362446 18775883 18253720 3124819 19004024 17942915 18282651 17854601 16842330 2563599 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
6.93 | 12151625 |
| MESH:D008133 |
Long QT Syndrome |
|
Amiodarone |
3.01 | 11989578 15350150 17391786 |
| MESH:D008171 |
Lung Diseases |
|
Acetylcysteine |
13.35 | 12815614 |
| MESH:D008171 |
Lung Diseases |
|
Amiodarone |
13.35 | 12587719 |
| MESH:D008171 |
Lung Diseases |
|
Mustard Gas |
13.35 | 18702808 18161513 |
| MESH:D008171 |
Lung Diseases |
|
Ozone |
13.35 | 8266340 19066396 |
| MESH:D017563 |
Lung Diseases, Interstitial |
|
Amiodarone |
3.74 | 18516814 |
| MESH:D055370 |
Lung Injury |
|
Ozone |
3.15 | 20417186 |
| MESH:D008175 |
Lung Neoplasms |
|
Azacitidine |
10.50 | 21224363 |
| MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
10.50 | 18569708 20869020 18816296 17053015 18520028 20064080 6695378 20135361 20464547 |
| MESH:D008175 |
Lung Neoplasms |
|
Curcumin |
10.50 | 18462866 19359593 16243823 |
| MESH:D008175 |
Lung Neoplasms |
|
deguelin |
10.50 | 19336726 16288123 |
| MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
10.50 | 20512841 20970405 21163286 6695378 |
| MESH:D008175 |
Lung Neoplasms |
|
Mustard Gas |
10.50 | 8781369 3148597 |
| MESH:D008175 |
Lung Neoplasms |
|
Ozone |
10.50 | 7614698 8597069 |
| MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
10.50 | 11884234 19555203 |
| MESH:D008181 |
Lupus Nephritis |
|
Diethylstilbestrol |
4.42 | 15166399 |
| MESH:D008207 |
Lymphatic Metastasis |
|
orlistat |
5.19 | 20805790 18770866 |
| MESH:D008223 |
Lymphoma |
|
Curcumin |
9.53 | 18462866 |
| MESH:D008223 |
Lymphoma |
|
Cyclophosphamide |
9.53 | 12854902 |
| MESH:D008223 |
Lymphoma |
|
Diethylstilbestrol |
9.53 | 15700306 |
| MESH:D016393 |
Lymphoma, B-Cell |
|
Cyclophosphamide |
8.23 | 16675587 |
| MESH:D016393 |
Lymphoma, B-Cell |
|
resveratrol |
8.23 | 17088997 |
| MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Cyclophosphamide |
7.00 | 11911406 |
| MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
resveratrol |
7.00 | 14749477 |
| MESH:D016399 |
Lymphoma, T-Cell |
|
Curcumin |
3.98 | 16173963 |
| MESH:D052801 |
Male Urogenital Diseases |
|
Diethylstilbestrol |
4.77 | 16002989 |
| MESH:D015674 |
Mammary Neoplasms, Animal |
|
resveratrol |
3.53 | 15688416 |
| MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
10.23 | 17203775 11807958 11408345 16891317 |
| MESH:D008325 |
Mammary Neoplasms, Experimental |
|
gefitinib |
10.23 | 18375820 |
| MESH:D008325 |
Mammary Neoplasms, Experimental |
|
resveratrol |
10.23 | 11606380 8985016 |
| MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Zinc |
10.23 | 12773700 |
| MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
3.74 | 19453300 |
| MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.44 | 17453147 |
| MESH:D008545 |
Melanoma |
|
2-methoxyestradiol-3,17-bis-O,O-sulfamate |
17.71 | 14970876 |
| MESH:D008545 |
Melanoma |
|
6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid |
17.71 | 17992120 |
| MESH:D008545 |
Melanoma |
|
Curcumin |
17.71 | 18462866 17885582 |
| MESH:D008545 |
Melanoma |
|
epigallocatechin gallate |
17.71 | 11746506 17992120 |
| MESH:D008545 |
Melanoma |
|
orlistat |
17.71 | 18770866 20805790 |
| MESH:D008545 |
Melanoma |
|
resveratrol |
17.71 | 17992120 |
| MESH:D008545 |
Melanoma |
|
sorafenib |
17.71 | 18445842 |
| MESH:D008545 |
Melanoma |
|
Thalidomide |
17.71 | 17089043 16098027 12829675 |
| MESH:D008545 |
Melanoma |
|
Tretinoin |
17.71 | 16752155 |
| MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
8.48 | 19513568 |
| MESH:D008546 |
Melanoma, Experimental |
|
Cyclophosphamide |
8.48 | 16388313 |
| MESH:D008569 |
Memory Disorders |
|
Curcumin |
3.47 | 17263510 |
| MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
3.71 | 16940565 |
| MESH:D007706 |
Menkes Kinky Hair Syndrome |
|
Copper |
5.15 | 17268249 17109627 |
| MESH:D008659 |
Metabolic Diseases |
|
resveratrol |
3.72 | 17112576 |
| MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.05 | 16801185 |
| MESH:D008679 |
Metaplasia |
|
Ozone |
4.36 | 10496685 |
| MESH:D009006 |
Monosomy |
|
Azacitidine |
5.34 | 19299654 |
| MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
2.61 | 16381670 |
| MESH:D009101 |
Multiple Myeloma |
|
Azacitidine |
12.90 | 19549372 18443271 |
| MESH:D009101 |
Multiple Myeloma |
|
Curcumin |
12.90 | 19372569 |
| MESH:D009101 |
Multiple Myeloma |
|
resveratrol |
12.90 | 17049120 17935668 16490592 14749477 17164350 16267019 |
| MESH:D009101 |
Multiple Myeloma |
|
Thalidomide |
12.90 | 16445831 15867202 15744524 19112201 15939924 17168659 19372569 19112817 15920492 15741222 |
| MESH:D009134 |
Muscular Atrophy, Spinal |
|
Curcumin |
16.96 | 17962980 |
| MESH:D009134 |
Muscular Atrophy, Spinal |
|
epigallocatechin gallate |
16.96 | 17962980 |
| MESH:D009134 |
Muscular Atrophy, Spinal |
|
resveratrol |
16.96 | 17962980 |
| MESH:D009135 |
Muscular Diseases |
|
orlistat |
8.39 | 18430571 |
| MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
8.39 | 16239165 |
| MESH:D009164 |
Mycobacterium Infections |
|
orlistat |
4.76 | 21442799 |
| MESH:D009181 |
Mycoses |
|
Amiodarone |
4.16 | 12754197 17974566 |
| MESH:D009190 |
Myelodysplastic Syndromes |
|
Azacitidine |
13.92 | 17611569 19805378 17596541 18720364 |
| MESH:D009190 |
Myelodysplastic Syndromes |
|
SU 5416 |
13.92 | 12649163 |
| MESH:D009190 |
Myelodysplastic Syndromes |
|
Thalidomide |
13.92 | 18720364 |
| MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
13.92 | 17596541 |
| MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
4.52 | 19151258 |
| MESH:D009203 |
Myocardial Infarction |
|
resveratrol |
4.52 | 17188708 16456233 16525036 17015251 16317513 17125593 |
| MESH:D017202 |
Myocardial Ischemia |
|
resveratrol |
7.03 | 17015251 17125593 |
| MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
7.03 | 12213967 |
| MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
6.33 | 16810080 |
| MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
6.33 | 16411023 |
| MESH:D009205 |
Myocarditis |
|
resveratrol |
4.03 | 17322642 |
| MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
7.94 | 18551238 |
| MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
7.94 | 7678174 18551238 |
| MESH:D009361 |
Neoplasm Invasiveness |
|
Curcumin |
8.68 | 18495463 |
| MESH:D009361 |
Neoplasm Invasiveness |
|
demethoxycurcumin |
8.68 | 18495463 |
| MESH:D009362 |
Neoplasm Metastasis |
|
Acetylcysteine |
4.92 | 14720322 |
| MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
4.92 | 9029167 3581430 |
| MESH:D009369 |
Neoplasms |
|
2,4,5,2',4',5'-hexachlorobiphenyl |
24.58 | 8820588 |
| MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
24.58 | 11141357 |
| MESH:D009369 |
Neoplasms |
|
Cyclophosphamide |
24.58 | 18854779 |
| MESH:D009369 |
Neoplasms |
|
deguelin |
24.58 | 17764071 |
| MESH:D009369 |
Neoplasms |
|
Diethylstilbestrol |
24.58 | 15313581 |
| MESH:D009369 |
Neoplasms |
|
orlistat |
24.58 | 18710210 |
| MESH:D009369 |
Neoplasms |
|
pirinixic acid |
24.58 | 17405874 |
| MESH:D009369 |
Neoplasms |
|
SU 5416 |
24.58 | 17264769 |
| MESH:D009369 |
Neoplasms |
|
Tretinoin |
24.58 | 16946489 16594593 |
| MESH:D009374 |
Neoplasms, Experimental |
|
orlistat |
7.40 | 19381703 |
| MESH:D009374 |
Neoplasms, Experimental |
|
resveratrol |
7.40 | 8985016 |
| MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Curcumin |
3.80 | 12497104 |
| MESH:D009389 |
Neovascularization, Pathologic |
|
2,3-bis(3'-hydroxybenzyl)butane-1,4-diol |
30.16 | 17289903 |
| MESH:D009389 |
Neovascularization, Pathologic |
|
2,3-bis(3'-hydroxybenzyl)butyrolactone |
30.16 | 17289903 |
| MESH:D009389 |
Neovascularization, Pathologic |
|
2-methoxyestradiol-3,17-bis-O,O-sulfamate |
30.16 | 17426705 |
| MESH:D009389 |
Neovascularization, Pathologic |
|
Copper |
30.16 | 17308104 |
| MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
30.16 | 17289903 |
| MESH:D009389 |
Neovascularization, Pathologic |
|
orlistat |
30.16 | 17012255 |
| MESH:D009397 |
Nephrocalcinosis |
|
Furosemide |
5.13 | 15086907 |
| MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
3.70 | 17954296 |
| MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
2.66 | 19348381 18481113 |
| MESH:D009421 |
Nervous System Malformations |
|
Diethylstilbestrol |
23.48 | 11399458 |
| MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
23.48 | 16427766 11399458 |
| MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
23.48 | 14600291 |
| MESH:D009421 |
Nervous System Malformations |
|
Thalidomide |
23.48 | 16859833 |
| MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
23.48 | 9125849 |
| MESH:D009423 |
Nervous System Neoplasms |
|
Curcumin |
4.89 | 18462866 |
| MESH:D009436 |
Neural Tube Defects |
|
Acetylcysteine |
5.93 | 19446573 |
| MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
5.93 | 9142499 |
| MESH:D019954 |
Neurobehavioral Manifestations |
|
2,3',4,4',5-pentachlorobiphenyl |
5.80 | 19647017 |
| MESH:D009447 |
Neuroblastoma |
|
Cyclophosphamide |
3.22 | 8761367 15176712 16115947 |
| MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
10.55 | 18514411 |
| MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
10.55 | 20387270 |
| MESH:D019636 |
Neurodegenerative Diseases |
|
resveratrol |
10.55 | 17652729 |
| MESH:D017599 |
Neuroectodermal Tumors |
|
Cyclophosphamide |
4.16 | 8761367 12837982 |
| MESH:D020078 |
Neurogenic Inflammation |
|
resveratrol |
3.72 | 17929310 |
| MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
4.38 | 20387270 |
| MESH:D009503 |
Neutropenia |
|
Cyclophosphamide |
7.30 | 8291058 |
| MESH:D009503 |
Neutropenia |
|
Mustard Gas |
7.30 | 7688884 16761898 |
| MESH:D052556 |
Niemann-Pick Disease, Type C |
|
Clofibrate |
4.23 | 9802331 |
| MESH:D053206 |
Nocturnal Enuresis |
|
Furosemide |
5.13 | 17945291 |
| MESH:C541083 |
Non-alcoholic Fatty Liver Disease |
|
orlistat |
4.90 | 17404856 |
| MESH:D009765 |
Obesity |
|
Curcumin |
8.62 | 19297423 |
| MESH:D009765 |
Obesity |
|
Dietary Fats |
8.62 | 17217161 11836018 18674790 20132043 21332399 18457598 16723640 20518802 19632207 |
| MESH:D009765 |
Obesity |
|
orlistat |
8.62 | 16938137 21438711 20518802 21442799 19207292 20540997 18773755 20599501 20002075 19461584 19046740 20065556 |
| MESH:D009765 |
Obesity |
|
pirinixic acid |
8.62 | 20558911 |
| MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
6.76 | 12819281 16049721 |
| MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
6.76 | 16049721 |
| MESH:D009845 |
Oligospermia |
|
Cyclophosphamide |
3.99 | 16517039 |
| MESH:D010009 |
Osteochondrodysplasias |
marker/mechanism |
|
| 17954590 |
| MESH:D010009 |
Osteochondrodysplasias |
|
Thiram |
4.95 | 15518828 15899490 17954590 |
| MESH:D010024 |
Osteoporosis |
|
Curcumin |
2.99 | 18719352 |
| MESH:D015663 |
Osteoporosis, Postmenopausal |
|
resveratrol |
3.58 | 17513867 |
| MESH:D010051 |
Ovarian Neoplasms |
|
Curcumin |
8.87 | 19020741 18462866 |
| MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
8.87 | 19401270 |
| MESH:D010051 |
Ovarian Neoplasms |
|
Thalidomide |
8.87 | 16288038 |
| MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
8.87 | 16936753 |
| MESH:D010146 |
Pain |
|
Acetaminophen |
7.84 | 16870215 |
| MESH:D010146 |
Pain |
|
Cyclophosphamide |
7.84 | 12161096 18093676 |
| MESH:D010146 |
Pain |
|
Tretinoin |
7.84 | 16870215 |
| MESH:D010190 |
Pancreatic Neoplasms |
|
Curcumin |
9.64 | 19401701 19196508 17440100 |
| MESH:D010190 |
Pancreatic Neoplasms |
|
Cyclophosphamide |
9.64 | 11332152 |
| MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
9.64 | 16540662 |
| MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
9.64 | 15976015 |
| MESH:D010195 |
Pancreatitis |
|
orlistat |
4.19 | 16938137 20065556 |
| MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.01 | 11578682 |
| MESH:D010291 |
Paresis |
|
Thalidomide |
5.56 | 9200351 |
| MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.51 | 12520081 |
| MESH:D010538 |
Peritonitis |
|
Ozone |
3.43 | 16369182 |
| MESH:D010900 |
Pituitary Diseases |
|
Diethylstilbestrol |
4.43 | 14722030 |
| MESH:D010911 |
Pituitary Neoplasms |
|
Diethylstilbestrol |
3.96 | 16977796 15687265 |
| MESH:D011014 |
Pneumonia |
|
Ozone |
3.67 | 18929643 18007984 18381685 |
| MESH:D011041 |
Poisoning |
|
Mustard Gas |
3.14 | 15727166 |
| MESH:D011085 |
Polycystic Ovary Syndrome |
|
orlistat |
4.63 | 17201808 |
| MESH:D011141 |
Polyuria |
|
Furosemide |
4.92 | 17945291 |
| MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
2.87 | 18163543 |
| MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
6.87 | 12371664 |
| MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
6.87 | 2563599 |
| MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Cyclophosphamide |
6.53 | 21297632 |
| MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Thalidomide |
6.53 | 17031469 |
| MESH:D011225 |
Pre-Eclampsia |
|
Zinc |
3.59 | 17114810 |
| MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Diethylstilbestrol |
17.36 | 17184923 |
| MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
resveratrol |
17.36 | 16679765 |
| MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
17.36 | 11118676 11222880 11896295 11399792 |
| MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
vinclozolin |
17.36 | 18042343 18220299 19015723 |
| MESH:D011469 |
Prostatic Diseases |
|
vinclozolin |
4.21 | 18220299 |
| MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.22 | 20887781 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Azacitidine |
4.26 | 18324645 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
4.26 | 17292933 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Copper |
4.26 | 17308104 17079463 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Curcumin |
4.26 | 10851300 18769126 11398177 15129424 18226269 12497104 18156803 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Cyclophosphamide |
4.26 | 17136230 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Diethylstilbestrol |
4.26 | 15046698 17136230 15846301 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
4.26 | 16740699 |
| MESH:D011471 |
Prostatic Neoplasms |
|
gefitinib |
4.26 | 17914592 15651060 16685379 |
| MESH:D011471 |
Prostatic Neoplasms |
|
resveratrol |
4.26 | 15767336 17804756 17718901 17636462 16731767 17675339 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Thalidomide |
4.26 | 16729912 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Thiram |
4.26 | 19789329 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Zinc |
4.26 | 16700911 16517595 16606632 12429649 |
| MESH:D011472 |
Prostatitis |
|
vinclozolin |
4.21 | 18629315 |
| MESH:D011507 |
Proteinuria |
|
Tretinoin |
7.36 | 16636307 |
| MESH:D011507 |
Proteinuria |
|
valsartan |
7.36 | 17664856 12164870 18344623 |
| MESH:D011536 |
Prurigo |
|
Thalidomide |
5.56 | 12755975 |
| MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
7.13 | 16919318 15861022 |
| MESH:D011537 |
Pruritus |
|
Mustard Gas |
7.13 | 18058305 |
| MESH:D011565 |
Psoriasis |
|
Cyclosporine |
1.92 | 16882103 |
| MESH:D011625 |
Pterygium |
|
Tretinoin |
4.06 | 16723453 |
| MESH:D011656 |
Pulmonary Emphysema |
|
Curcumin |
3.88 | 19168576 |
| MESH:D011658 |
Pulmonary Fibrosis |
|
Amiodarone |
13.76 | 12490602 12832656 11597910 |
| MESH:D011658 |
Pulmonary Fibrosis |
|
Cyclophosphamide |
13.76 | 16636934 |
| MESH:D011658 |
Pulmonary Fibrosis |
|
gefitinib |
13.76 | 18424623 |
| MESH:D011658 |
Pulmonary Fibrosis |
|
Mustard Gas |
13.76 | 17720292 17266442 17620002 17894541 10334151 |
| MESH:D011658 |
Pulmonary Fibrosis |
|
valsartan |
13.76 | 17241526 |
| MESH:D012035 |
Refsum Disease |
|
orlistat |
5.34 | 20871815 |
| MESH:D051436 |
Renal Insufficiency, Chronic |
|
resveratrol |
4.84 | 16325855 |
| MESH:D015427 |
Reperfusion Injury |
marker/mechanism |
|
| 16526316 |
| MESH:D015427 |
Reperfusion Injury |
|
Furosemide |
8.63 | 16526316 |
| MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
8.63 | 19058328 |
| MESH:D015427 |
Reperfusion Injury |
|
resveratrol |
8.63 | 15827377 16314181 16317513 17520802 17058453 |
| MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Acetylcysteine |
11.54 | 12210543 |
| MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Curcumin |
11.54 | 18379247 10666014 |
| MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Furosemide |
11.54 | 15912074 12394941 16096441 |
| MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.14 | 18990726 |
| MESH:D012162 |
Retinal Degeneration |
|
Zinc |
3.56 | 16584753 |
| MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
3.42 | 16283617 16116481 |
| MESH:D012509 |
Sarcoma |
|
Curcumin |
3.48 | 18462866 |
| MESH:D012559 |
Schizophrenia |
|
Copper |
2.97 | 16842975 |
| MESH:D019873 |
Schnitzler Syndrome |
|
Thalidomide |
5.21 | 16096327 |
| MESH:D012595 |
Scleroderma, Systemic |
|
Cyclophosphamide |
4.15 | 16636934 |
| MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
4.15 | 18551238 |
| MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
4.15 | 18551238 |
| MESH:D018805 |
Sepsis |
|
Curcumin |
3.47 | 18389075 |
| OMIM:609620 |
SHORT QT SYNDROME 1 |
|
Amiodarone |
4.36 | 18724381 |
| MESH:D012852 |
Sinusitis |
|
Phenylephrine |
3.98 | 7327846 |
| MESH:D012871 |
Skin Diseases |
|
Mustard Gas |
2.48 | 12880345 16961503 15451306 |
| MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
13.65 | 10029692 19755658 |
| MESH:D012878 |
Skin Neoplasms |
|
deguelin |
13.65 | 16041863 |
| MESH:D012878 |
Skin Neoplasms |
|
resveratrol |
13.65 | 15837718 8985016 |
| MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
13.65 | 16192470 |
| MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
13.65 | 16467112 |
| MESH:D013088 |
Spermatocele |
|
Diethylstilbestrol |
9.26 | 16709447 16002989 |
| MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
9.26 | 16709447 |
| OMIM:102530 |
SPERMATOGENIC FAILURE 6 |
|
Cyclophosphamide |
4.79 | 16517039 |
| MESH:D013272 |
Stomach Diseases |
|
Omeprazole |
3.89 | 18545984 |
| MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
5.21 | 2093021 20155912 |
| MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
5.21 | 18456281 |
| MESH:D013274 |
Stomach Neoplasms |
|
Furosemide |
5.21 | 17052386 |
| MESH:D013274 |
Stomach Neoplasms |
|
orlistat |
5.21 | 19381703 |
| MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
5.21 | 17261132 |
| MESH:D013276 |
Stomach Ulcer |
|
Acetylcysteine |
15.74 | 17918041 |
| MESH:D013276 |
Stomach Ulcer |
|
Amiodarone |
15.74 | 18087811 |
| MESH:D013276 |
Stomach Ulcer |
|
Curcumin |
15.74 | 16631530 19188055 |
| MESH:D013276 |
Stomach Ulcer |
|
Omeprazole |
15.74 | 17977527 18237397 15991576 10750652 11906479 16755016 |
| MESH:D013276 |
Stomach Ulcer |
|
Thalidomide |
15.74 | 15138204 |
| OMIM:601367 |
STROKE, ISCHEMIC |
|
resveratrol |
3.84 | 16321402 |
| MESH:D015173 |
Supratentorial Neoplasms |
|
Cyclophosphamide |
4.33 | 12837982 |
| MESH:D013610 |
Tachycardia |
|
Amiodarone |
3.60 | 11238279 |
| MESH:D017180 |
Tachycardia, Ventricular |
|
Amiodarone |
3.50 | 19225199 |
| MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
2.94 | 11994571 |
| MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
7.53 | 15669648 |
| MESH:D013927 |
Thrombosis |
|
SU 5416 |
7.53 | 12649163 |
| MESH:D013959 |
Thyroid Diseases |
|
Amiodarone |
9.59 | 19731979 |
| MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
9.59 | 12697716 |
| MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
16.48 | 7505956 |
| MESH:D013964 |
Thyroid Neoplasms |
|
gefitinib |
16.48 | 16940797 |
| MESH:D013964 |
Thyroid Neoplasms |
|
N-(4-bromo-2-fluorophenyl)-6-methoxy-7-((1-methylpiperidin-4-yl)methoxy)quinazolin-4-amine |
16.48 | 16940797 |
| MESH:D013964 |
Thyroid Neoplasms |
|
Propylthiouracil |
16.48 | 15710170 |
| MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
16.48 | 16026305 17045167 |
| MESH:D013971 |
Thyrotoxicosis |
|
Amiodarone |
4.15 | 18020914 19584973 |
| MESH:D013978 |
Tibial Fractures |
|
Estradiol |
3.94 | 19048282 |
| MESH:D014062 |
Tongue Neoplasms |
|
resveratrol |
12.94 | 16227395 |
| MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
12.94 | 16051514 |
| MESH:D014062 |
Tongue Neoplasms |
|
Zinc |
12.94 | 16543248 |
| MESH:D016171 |
Torsades de Pointes |
|
Amiodarone |
3.47 | 17467628 11989578 |
| MESH:D014376 |
Tuberculosis |
|
Tretinoin |
2.73 | 16040207 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
15.28 | 16049721 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
15.28 | 16049721 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
15.28 | 17053015 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
Curcumin |
15.28 | 18593936 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cyclophosphamide |
15.28 | 14692829 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
Diethylstilbestrol |
15.28 | 17306315 16452187 16712894 |
| MESH:D014565 |
Urogenital Neoplasms |
|
Curcumin |
4.54 | 18462866 |
| MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
9.58 | 10091137 |
| MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
9.58 | 10091137 |
| MESH:D014581 |
Urticaria |
|
Acetaminophen |
2.31 | 10982225 |
| MESH:D002583 |
Uterine Cervical Neoplasms |
|
Diethylstilbestrol |
12.23 | 16175088 |
| MESH:D002583 |
Uterine Cervical Neoplasms |
|
resveratrol |
12.23 | 17473185 |
| MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
12.23 | 16129372 |
| MESH:D014591 |
Uterine Diseases |
|
Diethylstilbestrol |
4.43 | 14652134 |
| MESH:D014594 |
Uterine Neoplasms |
|
Diethylstilbestrol |
12.09 | 15809267 16690809 |
| MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
12.09 | 14692618 |
| MESH:D014594 |
Uterine Neoplasms |
|
resveratrol |
12.09 | 17044934 |
| MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
3.87 | 16752155 |
| MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.24 | 1336536 |
| MESH:D014625 |
Vaginal Neoplasms |
|
Diethylstilbestrol |
3.73 | 16513791 16002989 |
| MESH:D014652 |
Vascular Diseases |
|
Thalidomide |
4.76 | 15741222 |
| MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
3.85 | 12125929 |
| MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
2.88 | 14671159 15869587 |
| MESH:D018487 |
Ventricular Dysfunction, Left |
|
resveratrol |
3.60 | 17488730 |
| MESH:D020257 |
Ventricular Remodeling |
|
valsartan |
4.97 | 19027736 |
| MESH:D014820 |
Vitiligo |
|
Tretinoin |
3.36 | 16761959 |
| MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.51 | 15886252 |
| MESH:D015430 |
Weight Gain |
|
Dietary Fats |
3.11 | 16723640 |
| MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.34 | 16287080 |
| MESH:D014947 |
Wounds and Injuries |
|
sphingosine 1-phosphate |
4.86 | 15541073 |
| MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
3.70 | 17120751 |